20
Views
1
CrossRef citations to date
0
Altmetric
Original Paper

Bioactive interleukin-1α is cytolytically released from Candida albicans-infected oral epithelial cells

, &
Pages 531-541 | Received 27 Aug 2002, Accepted 05 Jan 2003, Published online: 09 Jul 2009
 

Abstract

Oral epithelial cells are primary targets of Candida albicans in the oropharynx and may regulate the inflammatory host response to this pathogen. This investigation studied the mechanisms underlying interleukin-1α (IL-1α) release by oral epithelial cells and the role of IL-1α in regulating the mucosal inflammatory response to C. albicans. Infected oral epithelial cells released processed IL-1α protein in culture supernatants. The IL-1α generated was stored intracellularly and was released upon cell lysis. This was further supported by the fact that different C. albicans strains induced variable IL-1α release, depending on their cytolytic activity. IL-1α from C. albicans-infected oral epithelial cells upregulated proinflammatory cytokine secretion (IL-8 and GM-CSF) in uninfected oral epithelial or stromal cells. Our studies suggest that production of IL-1α, IL-8 and GM-CSF may take place in the oral mucosa in response to lytic infection of epithelial cells with C. albicans. This process can act as an early innate immune surveillance system and may contribute to the clinicopathologic signs of infection in the oral mucosa.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.